| 000 | 01647 a2200445 4500 | ||
|---|---|---|---|
| 005 | 20250516152849.0 | ||
| 264 | 0 | _c20140407 | |
| 008 | 201404s 0 0 eng d | ||
| 022 | _a1742-7843 | ||
| 024 | 7 |
_a10.1111/bcpt.12092 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aNielsen, Gorm | |
| 245 | 0 | 0 |
_aAlterations of N-3 polyunsaturated fatty acid-activated K2P channels in hypoxia-induced pulmonary hypertension. _h[electronic resource] |
| 260 |
_bBasic & clinical pharmacology & toxicology _cOct 2013 |
||
| 300 |
_a250-8 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aDocosahexaenoic Acids _xpharmacology |
| 650 | 0 | 4 | _aElectrophysiology |
| 650 | 0 | 4 |
_aEpoprostenol _xantagonists & inhibitors |
| 650 | 0 | 4 |
_aHypertension, Pulmonary _xdrug therapy |
| 650 | 0 | 4 |
_aHypoxia _xcomplications |
| 650 | 0 | 4 |
_aLung _xdrug effects |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMice |
| 650 | 0 | 4 |
_aPotassium Channels, Tandem Pore Domain _xgenetics |
| 650 | 0 | 4 |
_aPulmonary Artery _xdrug effects |
| 650 | 0 | 4 |
_aRNA, Messenger _xgenetics |
| 650 | 0 | 4 | _aUp-Regulation |
| 650 | 0 | 4 |
_aVasodilation _xdrug effects |
| 700 | 1 | _aWandall-Frostholm, Christine | |
| 700 | 1 | _aSadda, Veeranjaneyulu | |
| 700 | 1 | _aOliván-Viguera, Aida | |
| 700 | 1 | _aLloyd, Eric E | |
| 700 | 1 | _aBryan, Robert M | |
| 700 | 1 | _aSimonsen, Ulf | |
| 700 | 1 | _aKöhler, Ralf | |
| 773 | 0 |
_tBasic & clinical pharmacology & toxicology _gvol. 113 _gno. 4 _gp. 250-8 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1111/bcpt.12092 _zAvailable from publisher's website |
| 999 |
_c22796790 _d22796790 |
||